Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Paraparesis after extracorporeal membrane oxygenation: A report of two cases and review of literature
Neuro Trauma, Critical Care, and Sports Neurology
P16 - Poster Session 16 (5:30 PM-6:30 PM)
13-018

To report two cases of suspected spinal cord infarction resulting in paraparesis after use of Extracorporeal Membrane Oxygenation (ECMO) and review similar reported cases in the literature and recommendations for prevention of neurologic injury post-ECMO use.

Case 1 is a 55-year-old woman with pulmonary arterial hypertension and heart failure who underwent emergent surgery for acute cholecystitis, complicated by hemorrhagic and cardiogenic shock and placement of bilateral femoral venous-arterial (VA) ECMO for circulatory support. ECMO was removed after 11 days and she was found to have near-complete paraplegia and sensory deficit in the bilateral lower extremities. She was discharged to a rehabilitation facility after a month.

Case 2 is a 61-year-old woman with non-ischemic cardiomyopathy with a pacemaker, sarcoidosis and atrial fibrillation whose pacemaker malfunctioned leading to cardiogenic shock, requiring placement of VA ECMO and a temporary ventricular assist device, with subsequent development of a thigh hematoma. The devices were removed after 13 days, and an asymmetric paraparesis and sensory deficit were noticed. 

Literature search was performed using PubMed, Ovid and ClinicalKey databases for articles containing the following keywords: “Extracorporeal Membrane Oxygenation”, “ECMO”, “spinal cord infarction”, and “paraplegia”. No date or language limits were placed.

N/A - section together with "Conclusions"

Our two patients underwent serial exams, electrodiagnostic studies and imaging and spinal cord infarction was suspected in both. Similar cases and review articles in the literature were reviewed with attention to possible risk factors and recommendations for prevention of neurologic injury after ECMO use. Studies are needed to clarify whether the underlying condition (e.g. heart failure) or the use of ECMO itself could lead to suspected spinal cord infarction.

Authors/Disclosures
Niloofar Yari, MD (Baylor University Medical Center - Baylor Scott and White)
PRESENTER
Dr. Yari has nothing to disclose.
Ashley E. Anderson, MD (Houston Methodist - Department of Neurology) Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/Johnson&Johnson. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen.
Mohammad O. Nakawah, MD, FÂé¶¹´«Ã½Ó³»­ (Houston Methodist Hospital) Dr. Nakawah has nothing to disclose.
Sheetal Shroff, MD (Houston Methodist Hospital) Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca. Dr. Shroff has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.